Medicine
Nifedipine 30 mg extended-release tablet
Nifedipine 30 mg extended-release tablet is a generic prescription medicine for oral use, made by 25 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59°…
Key facts
- Active ingredient (INN)
- Nifedipine
- Brand
- Sold under the generic name
- Strength
- 30 mg
- Dosage form
- Extended-release tablet
- Route
- Oral
- Packs
- 100 tablets, 1000 tablets, 300 tablets and 106 more
- Manufacturers
- Zydus LifesciencesIndiaAlembic PharmaceuticalsIndiaAscend LaboratoriesIndiaAurobindo PharmaIndiaIngenus PharmaceuticalsOceanside PharmaceuticalsUpsher-Smith LaboratoriesChartwell RX25 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F). Protect from moisture and humidity.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C08CA05 Nifedipine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 27 September 2000
- Identifiers
- RxCUI 1812011, 198034, 1812013 +3DailyMed set ID 325acf27-4b2e-40e8-8344-bb6cc9959910, 1b98b011-793c-ed92-e063-6294a90ac2bc, b885b6b5-71c6-4799-8b23-5ee8c17938a0 +37NDC 71335-1550, 71610-841, 0904-7208 +37Application ANDA210614, ANDA202987, ANDA203126 +8
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 25 labelers. The register lists 109 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, extended release in 1 bottle | 68382-685-01 | Zydus LifesciencesIndia | 2 February 2018 |
| 1000 tablet, extended release in 1 bottle | 68382-685-10 | Zydus LifesciencesIndia | 2 February 2018 |
| 300 tablet, extended release in 1 bottle | 68382-685-95 | Zydus LifesciencesIndia | 2 February 2018 |
| 100 tablet, extended release in 1 bottle | 68382-688-01 | Zydus LifesciencesIndia | 18 August 2018 |
| 500 tablet, extended release in 1 bottle | 68382-688-05 | Zydus LifesciencesIndia | 18 August 2018 |
| 1000 tablet, extended release in 1 bottle | 68382-688-10 | Zydus LifesciencesIndia | 18 August 2018 |
| 90 tablet, extended release in 1 bottle | 68382-688-16 | Zydus LifesciencesIndia | 18 August 2018 |
| 10 blister pack in 1 carton / 10 tablet, extended release in 1 blister pack | 68382-688-77 | Zydus LifesciencesIndia | 18 August 2018 |
| 300 tablet, extended release in 1 bottle | 68382-688-95 | Zydus LifesciencesIndia | 18 August 2018 |
| 1000 tablet, extended release in 1 bottle | 70771-1190-0 | Zydus LifesciencesIndia | 2 February 2018 |
| 100 tablet, extended release in 1 bottle | 70771-1190-1 | Zydus LifesciencesIndia | 2 February 2018 |
| 300 tablet, extended release in 1 bottle | 70771-1190-3 | Zydus LifesciencesIndia | 2 February 2018 |
| 1000 tablet, extended release in 1 bottle | 70771-1365-0 | Zydus LifesciencesIndia | 18 August 2018 |
| 100 tablet, extended release in 1 bottle | 70771-1365-1 | Zydus LifesciencesIndia | 18 August 2018 |
| 10 blister pack in 1 carton / 10 tablet, extended release in 1 blister pack | 70771-1365-4 | Zydus LifesciencesIndia | 18 August 2018 |
| 500 tablet, extended release in 1 bottle | 70771-1365-5 | Zydus LifesciencesIndia | 18 August 2018 |
| 300 tablet, extended release in 1 bottle | 70771-1365-7 | Zydus LifesciencesIndia | 18 August 2018 |
| 90 tablet, extended release in 1 bottle | 70771-1365-9 | Zydus LifesciencesIndia | 18 August 2018 |
| 100 tablet, extended release in 1 bottle | 46708-732-31 | Alembic PharmaceuticalsIndia | 23 November 2022 |
| 300 tablet, extended release in 1 bottle | 46708-732-63 | Alembic PharmaceuticalsIndia | 23 November 2022 |
| 1000 tablet, extended release in 1 bottle | 46708-732-91 | Alembic PharmaceuticalsIndia | 23 November 2022 |
| 100 tablet, extended release in 1 bottle | 62332-732-31 | Alembic PharmaceuticalsIndia | 23 November 2022 |
| 300 tablet, extended release in 1 bottle | 62332-732-63 | Alembic PharmaceuticalsIndia | 23 November 2022 |
| 1000 tablet, extended release in 1 bottle | 62332-732-91 | Alembic PharmaceuticalsIndia | 23 November 2022 |
| 100 tablet, extended release in 1 bottle | 67877-757-01 | Ascend LaboratoriesIndia | 30 March 2022 |
| 500 tablet, extended release in 1 bottle | 67877-757-05 | Ascend LaboratoriesIndia | 30 March 2022 |
| 300 tablet, extended release in 1 bottle | 67877-757-58 | Ascend LaboratoriesIndia | 30 March 2022 |
| 90 tablet, extended release in 1 bottle | 67877-757-90 | Ascend LaboratoriesIndia | 30 March 2022 |
| 100 tablet, extended release in 1 bottle | 59651-295-01 | Aurobindo PharmaIndia | 19 July 2021 |
| 100 tablet, film coated, extended release in 1 bottle | 50742-260-01 | Ingenus Pharmaceuticals | 12 March 2019 |
| 300 tablet, film coated, extended release in 1 bottle | 50742-260-03 | Ingenus Pharmaceuticals | 12 March 2019 |
| 30 tablet, film coated, extended release in 1 bottle | 50742-260-30 | Ingenus Pharmaceuticals | 12 March 2019 |
| 100 tablet, extended release in 1 bottle | 50742-620-01 | Ingenus Pharmaceuticals | 15 February 2017 |
| 100 tablet, extended release in 1 bottle | 68682-105-10 | Oceanside Pharmaceuticals | 18 October 2012 |
| 300 tablet, extended release in 1 bottle | 68682-105-30 | Oceanside Pharmaceuticals | 18 October 2012 |
| 100 tablet, film coated, extended release in 1 bottle | 68682-108-10 | Oceanside Pharmaceuticals | 27 September 2000 |
| 300 tablet, film coated, extended release in 1 bottle | 68682-108-30 | Oceanside Pharmaceuticals | 27 September 2000 |
| 100 tablet, film coated, extended release in 1 bottle | 24979-011-01 | Upsher-Smith Laboratories | 1 November 2014 |
| 300 tablet, film coated, extended release in 1 bottle | 24979-011-12 | Upsher-Smith Laboratories | 15 May 2015 |
| 90 tablet, film coated, extended release in 1 bottle | 62135-521-90 | Chartwell RX | 11 April 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 31 December 1981 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Nifedipine 30 mg extended-release tablet.
Other strengths and forms of Nifedipine
Clinical summary
Nifedipine is a dihydropyridine calcium channel blocker indicated for the management of vasospastic angina confirmed by any of criteria, among other approved uses. It is available as extended-release tablets and capsules for oral use. MedsAcross supplies Nifedipine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about NifedipineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Procardia XL prescribing information (Pfizer Laboratories) · U.S. National Library of Medicine, DailyMed
Need Nifedipine 30 mg extended-release tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.